Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Relapsed or Refractory Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Selinexor, Cyclophosphamide and Prednisone in Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Study of BEBT-908 in Subjects With Advanced Hematological Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- NA
A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1